Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001758866-24-000004·ADAR1 Partners, LP
Schedule 13G ownership disclosure
HOMOLOGY MEDICINES INC
Common Stock, $0.0001 par value per share · CUSIP: 438083107
Event date: 2024-03-04
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ADAR1 Partners, LP
Shares: 3,120,824.00 · Class: 5.4%
- ADAR1 Capital Management, LLC
Shares: 3,120,824.00 · Class: 5.4%
- ADAR1 Capital Management GP, LLC
Shares: 3,120,824.00 · Class: 5.4%
- Daniel Schneeberger
Shares: 3,120,824.00 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001758866-24-000004
- Form type
- SCHEDULE 13G
- Filer
- ADAR1 Partners, LP
- CIK
- CIK 1758866
- Filed
- Mar 14, 2024
- Reporting period
- Mar 04, 2024
- Description
- Schedule 13G beneficial ownership